Adoption and Reasons for Withdrawal of ICH Q1F Guidelines
1, 2, 1★★ Corresponding author
- 1Department of Pharmaceutical Quality Assurance, Manipal College of Pharmaceutical Sciences, Manipal-576104, Karnataka, INDIA.
- 2Department of Pharmaceutics, Manipal College of Pharmaceutical Sciences, Manipal-576104, Karnataka, INDIA.
CORRESPONDENCE
Muddukrishna Badamane Sathyanarayana
Department of Pharmaceutical Quality Assurance, Manipal College of Pharmaceutical Sciences, Manipal-576104, Karnataka, INDIA.
Volume 8, Issue 4 · pp. 500-504 · 2016 · DOI: 10.5530/jyp.2016.4.31
ABSTRACT
ICH Q1 F guideline provided astability data package for the registration applications of drug substance and drug product in Climatic Zones III (hot and dry) and IV (hot and humid). These guidelines were adopted by the ICH in February 2003 and subsequently implemented in the ICH regions. Due to some reasons the guidelines were withdrawn. This review article describes the development of the concept of the climatic zones, the introduction of the guideline Q1F, its adoption, objections to these guidelines, its withdrawal and reasons for the withdrawal and its alaternative that was proposed.
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Jadeja, S., kulyadi, G. P., & Sathyanarayana, M. B. (2016). Adoption and Reasons for Withdrawal of ICH Q1F Guidelines. Journal of Young Pharmacists, 8(4), 500-504. https://doi.org/10.5530/jyp.2016.4.31
Copyright and licence
© 2016 Author(s)
This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. CC BY-NC-SA 4.0